Grant: CIHR Fellowship
Direct Payment
$100,000.00
Mechanisms of behaviour change in pharmacological treatments for adolescent risky alcohol use: a focus on emotional processes
EF 2021-22
Résumé
Alcohol use disorder (AUD) is estimated to cost Canadian society $14.6 billion and is associated with detrimental individual and societal effects. AUD often begins in adolescence, and yet, AUD treatments for adolescents tend to be less effective compared to treatments for adults. One reason they lag behind may the lack of scientific knowledge about how AUD treatments work. As such, more research is needed to uncover the psychological processes in treatment that predict improvements in AUD (i.e., decreases in alcohol craving and alcohol use). Two novel medications (atomoxetine and lamotrigine) show promise as AUD treatments, but the way in which they affect AUD symptoms remains unknown. For those with AUD, alcohol is often used to relieve negative emotions. Thus, one way to decrease alcohol craving and alcohol use may be to improve mood and emotion regulation (i.e., the ability to manage one's emotions). Despite the theoretical importance of these emotional processes in AUD, there is little work examining them as mechanisms in treatment. Both atomoxetine and lamotrigine have shown to improve emotional states, making improved mood and emotion regulation likely mechanisms by which these medications may improve AUD symptoms. The focus of my proposed research is to test this hypothesis.
The study question will be examined in two randomized controlled trials for atomoxetine and lamotrigine in conjunction to a psychological intervention for AUD in adolescents. Participants aged 14-19 years (N = 42 for each study) are randomized to active medication or a placebo, plus a behavioural platform for 6 weeks. Participants complete daily morning reports as well 4 daily reports that measure daily mood, emotion regulation, and alcohol outcomes.
Findings from this research will help identify how medications for AUD work. This will allow for the development of more effective treatments for AUD in youth and, as such, increase the well-being of those struggling with AUD.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Rhode Island, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
454902
Name
Jenzer Tiffany
Region
Rhode Island
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Health Research Training A - Post-PhD (HTA)
Projecttitle
Mechanisms of behaviour change in pharmacological treatments for adolescent risky alcohol use: a focus on emotional processes
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Adolescence; Ecological Momentary Assessment; Emotion Regulation; Mechanisms Of Behaviour Change; Pharmacotherapy; Problematic Alcohol Use
Abstract
Alcohol use disorder (AUD) is estimated to cost Canadian society $14.6 billion and is associated with detrimental individual and societal effects. AUD often begins in adolescence, and yet, AUD treatments for adolescents tend to be less effective compared to treatments for adults. One reason they lag behind may the lack of scientific knowledge about how AUD treatments work. As such, more research is needed to uncover the psychological processes in treatment that predict improvements in AUD (i.e., decreases in alcohol craving and alcohol use). Two novel medications (atomoxetine and lamotrigine) show promise as AUD treatments, but the way in which they affect AUD symptoms remains unknown. For those with AUD, alcohol is often used to relieve negative emotions. Thus, one way to decrease alcohol craving and alcohol use may be to improve mood and emotion regulation (i.e., the ability to manage one's emotions). Despite the theoretical importance of these emotional processes in AUD, there is little work examining them as mechanisms in treatment. Both atomoxetine and lamotrigine have shown to improve emotional states, making improved mood and emotion regulation likely mechanisms by which these medications may improve AUD symptoms. The focus of my proposed research is to test this hypothesis.
The study question will be examined in two randomized controlled trials for atomoxetine and lamotrigine in conjunction to a psychological intervention for AUD in adolescents. Participants aged 14-19 years (N = 42 for each study) are randomized to active medication or a placebo, plus a behavioural platform for 6 weeks. Participants complete daily morning reports as well 4 daily reports that measure daily mood, emotion regulation, and alcohol outcomes.
Findings from this research will help identify how medications for AUD work. This will allow for the development of more effective treatments for AUD in youth and, as such, increase the well-being of those struggling with AUD.
Competitiondate
202110
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Jenzer, Tiffany
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $100,000~ $0~